Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients

Abstract The assessment of ctDNA has emerged as a minimally invasive avenue for molecular diagnosis and real-time tracking of tumor progression in NSCLC. However, the evaluation of ctDNA by amplicon-based NGS has been not endorsed by all the healthcare systems and remains to be fully integrated into...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Valerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, Andrea Gottardo, Francesco Pepe, Gianluca Russo, Fabio Fulfaro, Lorena Incorvaia, Giuseppe Badalamenti, Giancarlo Troncone, Umberto Malapelle, Antonio Russo, Viviana Bazan, Antonio Galvano
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-09-01
coleção:	Scientific Reports
Assuntos:	NSCLC Liquid biopsy CtDNA NGS Monitoring
Acesso em linha:	https://doi.org/10.1038/s41598-024-73046-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!